多发性脑膜瘤的管理
该研究回顾了25年间连续收治的133例成人多发性脑膜瘤患者(排除2型神经纤维瘤病),共395个同时性及53个异时性脑膜瘤。约三分之二患者需治疗但仅三分之一肿瘤需积极干预,作者建议对稳定无症状者随访、对有症状或生长者治疗。
要点
- 多发性脑膜瘤常无症状,可能因多数肿瘤较小且相当比例由放疗诱发。
- 约三分之二患者需治疗,但全部脑膜瘤中仅三分之一需积极治疗。
- 作者建议对稳定且无症状的脑膜瘤行随访,对有症状或生长者行治疗。
核心结论
- 多发性脑膜瘤常无症状,可能因多数肿瘤较小且相当比例由放疗诱发。
- 约三分之二多发性脑膜瘤患者需治疗,但全部脑膜瘤中仅三分之一需积极治疗。
- 作者建议对稳定且无症状的脑膜瘤行随访,对有症状或生长者行治疗。
研究设计与样本
- 回顾性连续队列,纳入≥2个空间分离的脑膜瘤的成人患者,排除2型神经纤维瘤病。
- 共133例患者,25年间收治,共395个同时性及53个异时性脑膜瘤,每例中位2个肿瘤。
主要发现
- 106例为散发性,26例为放疗诱发,1例为家族性脑膜瘤病。
- 初诊时半数患者无症状;按最大横截面直径,67%肿瘤≤2 cm,11%>4 cm。
- 54例 upfront 治疗,31例观察后延迟治疗(平均4年);四分之一患者有≥2个脑膜瘤接受治疗。
- 总体64%患者针对142个肿瘤接受治疗——67个手术,18个单纯放疗;平均随访7年,13%治疗患者接受挽救治疗。
- 接受手术的患者中约四分之一有≥1个WHO II级或III级脑膜瘤;同一患者不同组织学亚型和级别并不少见。
临床怎么用
- 作者建议对稳定且无症状的脑膜瘤行随访,对有症状或生长者行治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Multiple meningiomas account for 1%-10% of meningiomas. This study describes epidemiological aspects of the disease and its management, which is more challenging than for single tumors. METHODS A consecutive series of adult patients with ≥ 2 spatially separated meningiomas was reviewed. Patients with neurofibromatosis Type 2 were excluded. The authors collected clinical, imaging, histological, and treatment data to obtain information on epidemiology, management options, and outcomes of active treatment and surveillance. RESULTS A total of 133 consecutive patients were included over 25 years, with a total of 395 synchronous and 53 metachronous meningiomas, and a median of 2 tumors per patient. One hundred six patients had sporadic disease, 26 had radiation-induced disease, and 1 had familial meningiomatosis. At presentation, half of the patients were asymptomatic. In terms of their maximum cross-sectional diameter, the tumors were small (≤ 2 cm) in 67% and large (> 4 cm) in 11% of the meningiomas. Fifty-four patients had upfront treatment, and 31 had delayed treatment after an observation period (mean 4 years). One in 4 patients had ≥ 2 meningiomas treated. Overall, 64% of patients had treatment for 142 tumors-67 with surgery and 18 with radiotherapy alone. The mean follow-up was 7 years, with 13% of treated patients receiving salvage therapy. Approximately 1 in 4 patients who underwent surgery had ≥ 1 WHO Grade II or III meningioma. Meningiomas of different histological subtypes and grades in the same patient were not uncommon. CONCLUSIONS Multiple meningiomas are often asymptomatic, probably because the majority are small and a significant proportion are induced by radiation. Approximately two-thirds of patients with multiple meningiomas require therapy, but only one-third of all meningiomas need active treatment. The authors recommend surveillance for stable and asymptomatic meningiomas and therapy for those that are symptomatic or growing.
引用
- Tsermoulas G, Turel MK, Wilcox JT, et al. Management of multiple meningiomas. J Neurosurg. 2017. PMID: 28731398. doi:10.3171/2017.2.JNS162608
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。